Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off ...
Nearly three months after the Tennessee Health Department said it would no longer accept and distribute federal funding for HIV prevention-related services, the U.S. Centers for Disease Control and ...
CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...
Editor's note: This story has been updated to clarify which federal programs will not be impacted. Organizations across Tennessee were informed Wednesday that federal funding they have for years ...
A new analysis finds that generic lenacapavir, a twice-yearly HIV preventive treatment, could be mass produced for just $25 ...
ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a milestone in its transformative ...
MUMBAI: A US-trained commercial pilot with HIV on Tuesday told the Bombay HC that Directorate General of Civil Aviation (DGCA ...
HBcAb-positive, HBsAg-negative people with HIV can safely switch from tenofovir-containing ART without clinically significant HBV reactivation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback